Stay updated with breaking news from Michael Wechsler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite the finding, the authors suggest further research is done to better understand the mechanisms behind the interactions between asthma, sleep, and depression.
A lot of improvements in a lot of areas are coming, says Michael E. Wechsler, MD
The MANDARA trial results, published in NEJM, show benralizumab's noninferiority to mepolizumab in eosinophilic granulomatosis with polyangiitis, with potential for oral glucocorticoid discontinuation.
FASENRA enabled patients to taper off oral corticosteroids while preventing relapses ...
23.02.2024 - Positive results from the MANDARA Phase III trial for FASENRA (benralizumab) in patients with EGPA were published in the New England Journal of Medicine today,1 as the first head-to-head trial of biologics in patients with EGPA,2 and the first to ...